Navigating FDA & EMA Regulations for Retinal Disease Treatments

On June 26, 2024, the Foundation Fighting Blindness hosted an enlightening webinar focused on navigating the complexities of regulatory agencies. Tailored for scientists and companies developing treatments for inherited retinal diseases and dry age-related macular degeneration (dry AMD), this session provided valuable insights and practical advice. Dr. Cheryl Rowe-Rendleman from Omar Consulting Group shared her expertise on effectively interacting with the FDA and EMA, covering their roles, regulatory pathways, and submission processes. Watch this video to gain crucial knowledge and advance your R&D projects toward clinical utilization.